Navigation Links
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
Date:10/22/2008

on an Adjusted Basis:

Cost of sales increased 1 percent to $590 million in the third quarter of

2008 versus $585 million in the third quarter of 2007. This increase was

due to higher sales volume offset by lower excess inventory write-offs,

lower excess capacity charges and lower cost ENBREL. The Company now

expects full year 2008 adjusted Cost of Sales expense as a percent of

sales to be approximately 15 percent.

Research & Development (R&D) expenses were relatively unchanged at $700

million in the third quarter of 2008 versus $699 million in the third

quarter of 2007. Higher staff-related costs as well as clinical trial

spend for our emerging pipeline were offset by lower clinical trial costs

for our denosumab registrational studies due to completion of enrollment

and the benefit derived from our licensing transaction with Takeda in

Japan. The Company now expects full year 2008 adjusted R&D expense

dollars to be slightly lower than 2007. Consistent with historical

spending patterns, the Company expects an increase in the fourth quarter

versus the third quarter that should be similar in magnitude to the

increase in 2007, though actual results may vary depending on licensing

activities and pipeline progress.

Selling, General & Administrative (SG&A) expenses increased 11 percent to

$890 million in the third quarter of 2008 versus $804 million in the

third quarter of 2007 reflecting higher Wyeth profit share expenses and

staff-related costs offset by lower litigation expense. Wyeth profit

share expenses increased 22 percent to $298 million in the third quarter

of 2008 versus $245 million in the third quarter of 2007. The Company

still expects Wyeth profit share to be one third of adjusted SG&A

expenses for the full year 2008. Excluding Wyeth profit share, adjusted

SG&A ex
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. CNS Response Announces Fiscal Third Quarter 2007 Results
2. Avitar Reports Third Quarter Financial Results for Fiscal 2007
3. Martek to Announce Third Quarter 2007 Results on September 5, 2007
4. Third Security, LLC Hires Two New Managing Directors
5. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
6. ThirdBiotech Networking Group Launches
7. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
8. PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call
9. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
10. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... the 30-day review period following the filing of ... indications with the U.S. Food and Drug Administration ... active. Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:8/31/2015)... HAYWARD, Calif. and SHANGHAI ... Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, ... Phase 2 clinical study for its lead drug ... designed to treat drug-resistant bacteria such as MRSA ... safer and better tolerated therapeutic option than currently ...
(Date:8/31/2015)... CAESAREA, Israel , Aug. 31, 2015 /PRNewswire/ ... the Dario™ Diabetes Management Solution, today announced it ... $2.5 million. Funds will be used to support ... of the Dario, a mobile, cloud-based, diabetes management ... a stylish, ,all-in-one, pocket-sized, blood glucose monitoring device, ...
(Date:8/31/2015)... Morton Grove, IL (PRWEB) , ... August 31, ... ... genotoxic impurities (PGIs), as a high priority in the drug development approval process. ... process. , This year, Regis Technologies, Inc., a Chicago-based CMO, has been ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
... some catching up to do even among Midwestern states ... to the latest Midwest Health Care Venture Investment Report. ... investments in 12 states or regions in the Midwest ... times the investment Wisconsin had. , ,These aren't comprehensive ...
... Madison Internet service provider SupraNet plans to ... the Aidmatrix Foundation, a global disaster-relief firm run by ... CEO Bryan Chan said in a press release that ... number of recent disasters the charity is responding to, ...
... headquarters in Madison, said it has agreed to trade five ... exchange for acquiring most of the customers Integra Telecom Inc. ... and Grand Forks in North Dakota, and Little Falls, Nisswa ... approval, the deal is expected to close within 90 days. ...
Cached Biology Technology:
(Date:9/1/2015)... Sept. 1, 2015  Automation and pre-processing are ... passenger screening. This is the first step toward ... will become unintrusive. An assortment of portal scanners, ... background investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
(Date:8/31/2015)... BURNABY, Canada , August 31, 2015 ... use of biometrics technology in government digitization projects to drive ... According to a recently published TechSci Research report, " India ... India is projected to grow at ... in the market is anticipated on account of extensive use ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Arabia Biomedical Sensors market is estimated at $0.23 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2
... NJIT and University of Sao Paulo today announced a ... safe, building block chemical derived from corn known as ... forward in developing applications and markets for corn-based chemistry. ... right to work with companies interested in sub-licensing this ...
... the University of Sheffield have shown how bacteria could ... in the journal Bioinformatics, could have significant ... sustainable fuels in the future. Like all living ... sequence of chemical reactions that transform nutrients into energy ...
... old ideas about water behavior are all wet., Ubiquitous on ... and in molecular clouds in interstellar space. Now, scientists say ... thought., "Water, as we know it, does not exist within ... Lycan Professor of Chemistry at the University of Illinois. "Water ...
Cached Biology News:Iowa Corn Promotion Board, NJIT to license breakthrough, safe bio-plastic alternative 2Water is 'designer fluid' that helps proteins change shape, scientists say 2
Agarose Gel Loading Dye Mixture 6X...
Pharmalyte, narrow range pH 4.2-4.9, 25 ml. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Immobiline for IEF and Carrier Ampholytes....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Biology Products: